N.C. Business Group on Health on a mission to lower healthcare costs

NCBGH CEO says biosimilars — therapies developed to compete with biologic products once patents have expired — can reduce costs by promoting competition and add therapeutic options to the marketplace.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news